4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine479633-63-1 CAS NO.479633-63-1
- FOB Price: USD: 10.00-10.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
99%(1-10)Kilogram
- Product Details
Keywords
- Tofacitinib intermediate
- Tofacitinib supplier
- low price Tofacitinib intermediate
Quick Details
- ProName: 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyri...
- CasNo: 479633-63-1
- Molecular Formula: C13H10ClN3O2S
- Appearance: solid
- Application: Tofacitinib intermediate
- DeliveryTime: within 1 week
- PackAge: 25kg/package
- Port: Wuhan
- ProductionCapacity: 1000 Kilogram/Month
- Purity: 98%min
- Storage: Store in dry place. Avoid Moisture.tig...
- Transportation: by air
- LimitNum: 1 Kilogram
- Moisture Content: 1.0%max
- Impurity: 0.5%max
Superiority
Wuhan Sunrise Technology Development Company limited(Wuhan Sunrise Pharmaceutical Tehcnology Co., Ltd) Wuhan Sunrise Technology Development Company limited is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The main business are R&D, technology transfer and technical services of APIs and pharmaceutical intermediates; R&D, manufacture and sales of PIs. Moreover, we have the right of dealing self-managed imp & exp business.
Main products:
Chemical synthesis series:
anti-cancer pharmaceutical intermediates,
ophthalmology APIs and related intermediates
Biological series: Mabs
Purity: 98%min.W e can offer the quantity from R&D to commercial quantities.We can support with TDP documents for support. The series are our most important pharmaceutical projects
Details
Purity: 98%min.W e can offer the quantity from R&D to commercial quantities.We can support with TDP documents for support. The series are our most important pharmaceutical projects
Wuhan Sunrise Technology Development Company limited(Wuhan Sunrise Pharmaceutical Tehcnology Co., Ltd) Wuhan Sunrise Technology Development Company limited is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The main business are R&D, technology transfer and technical services of APIs and pharmaceutical intermediates; R&D, manufacture and sales of PIs. Moreover, we have the right of dealing self-managed imp & exp business.
Main products:
Chemical synthesis series:
anti-cancer pharmaceutical intermediates,
ophthalmology APIs and related intermediates
Biological series: Mabs